NCT05708807 FIND Stroke Recovery - A Longitudinal Study
| NCT ID | NCT05708807 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Göteborg University |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2018-02-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2018-02-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Stroke survivors frequently suffer disabilities including motor and cognitive problems, impairments in speech and vision, depression, and several other disabilities that worsen their quality of life. Some will recover fully after stroke and others will have permanent impairments. Few studies show trajectories of recovery in different domains after stroke, hence recovery time-lines are not fully known. Also, the whole range of mechanisms leading to recovery are not precisely known (1). To monitor those mechanisms one can utilize biomarkers. In parallel to the studies of recovery, studies on time series of biomarkers after stroke are limited (2). Hence, a crucial first step to increase knowledge on biomarkers of stroke recovery is to gain a better understanding of the time course of both stroke recovery and biomarker patterns. Biomarkers can later be used for outcome predictions after stroke.
Eligibility Criteria
Investigators enrol patients presenting with first-ever ischemic stroke or intracerebral haemorrhage admitted to the stroke units at the Sahlgrenska University Hospital in Gothenburg, Sweden. The inclusion criteria are: • first-ever acute ischemic stroke; or intracerebral hemorrhage. The exclusion criteria are: * pre-stroke mRS score of ≥3; * severe neurodegenerative disease, cerebral neoplasm or terminal illness; and * patients considered unlikely to be able to participate in or to understand and/or comply with study procedures during follow-up visits at the hospital.
Contact & Investigator
Christina Jern, MD, PhD
PRINCIPAL INVESTIGATOR
Inst. of Biomedicine, the Sahlgrenska Academy, Univ. of Gothenburg
Frequently Asked Questions
Who can join the NCT05708807 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05708807 currently recruiting?
Yes, NCT05708807 is actively recruiting participants. Contact the research team at christina.jern@neuro.gu.se for enrollment information.
Where is the NCT05708807 trial being conducted?
This trial is being conducted at Gothenburg, Sweden.
Who is sponsoring the NCT05708807 clinical trial?
NCT05708807 is sponsored by Göteborg University. The principal investigator is Christina Jern, MD, PhD at Inst. of Biomedicine, the Sahlgrenska Academy, Univ. of Gothenburg. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.